Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
Press release Ahead of World TB Day, Unitaid and FIND welcome WHO resources to accelerate access to faster, more accurate tests for drug-resistant tuberculosis.
DxConnect test directories Searchable directories of diagnostic tests for various diseases under the DxConnect umbrella.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Scientific articles Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research The Lancet - Global Health, Tobias Broger, et al. 17 June 2024
Scientific articles Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile development The Lancet - Global Health, Alexandra de Nooy, et al. 12 June 2024
Scientific articles Implementation pilot study of community self-testing for COVID-19 among employees of manufacturing industries and their household members in 2022 to 2023 PLOS Global Public Health, Huan Keat Chan, et al. 5 June 2024
Scientific articles Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya BMC Trials, Elena Marbán-Castro, et al. 21 May 2024
Scientific articles Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness BMC Harm Reduction Journal, Nalinikanta Rajkumar, et al. 20 May 2024
Scientific articles Cost-effectiveness of diagnostic tools and strategies for the screening and diagnosis of tuberculosis disease and infection: a scoping review BMJ Public Health, Tom Ockhuisen, et al. 20 April 2024
Scientific articles Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines) BMJ Open, Megan A Hansen, et al. 17 April 2024
Scientific articles Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise The Lancet Respiratory Medicine, Anna K Coussens, et al. 22 March 2024
Scientific articles Potential implications of the climate crisis on diagnostics PLOS Global Public Health, Bernard Owusu Agyare, et al. 8 March 2024
Scientific articles Estimates of hospitalisations and deaths in patients with COVID-19 associated with undiagnosed diabetes during the first phase of the pandemic in eight low-income and middle-income countries: a modelling study eClinical Medecine, Amit Summan, et al. 5 March 2024